{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:25Z","timestamp":1791229465268,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejim.2018.05.034","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T14:35:15Z","timestamp":1544106915000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-9944","authenticated-orcid":false,"given":"Wilma","family":"Barcellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fattizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.05.034_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1191\/0961203303lu383ed","article-title":"Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly","volume":"12","author":"Ramos-Casals","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.ejim.2018.05.034_bb0010","first-page":"225","article-title":"Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction","volume":"12","author":"Ershler","year":"1993","journal-title":"Lymphokine Cytokine Res"},{"key":"10.1016\/j.ejim.2018.05.034_bb0015","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/1097-0142(19911201)68:11+<2496::AID-CNCR2820681503>3.0.CO;2-B","article-title":"Gerontology as oncology. Research on aging as the key to the understanding of cancer","volume":"68","author":"Miller","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2018.05.034_bb0020","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.4049\/jimmunol.137.8.2411","article-title":"Effect of age on the capacity of the bone marrow and the spleen cells to generate B lymphocytes","volume":"137","author":"Francus","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4049\/jimmunol.105.4.964","article-title":"The effect of aging on human serum immunoglobulin concentrations","volume":"105","author":"Buckley","year":"1970","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0030","first-page":"287","article-title":"Autoimmune phenomena in the elderly","volume":"119","author":"P\u00e9rez","year":"1991","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.ejim.2018.05.034_bb0035","first-page":"439","article-title":"A novel class of antitumour antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice","volume":"9","author":"Iakoubov","year":"1997","journal-title":"Oncol Res"},{"key":"10.1016\/j.ejim.2018.05.034_bb0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/096120339500400611","article-title":"Anticardiolipin antibodies in two elderly subpopulations","volume":"4","author":"Juby","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.ejim.2018.05.034_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000017211","article-title":"Dementia and antiphospholipid antibodies","volume":"11","author":"Mosek","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.ejim.2018.05.034_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3324\/haematol.10546","article-title":"Anti-erythroblast autoimmunity in early myelodysplastic syndromes","volume":"92","author":"Barcellini","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2018.05.034_bb0055","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.leukres.2013.09.001","article-title":"Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns","volume":"37","author":"Barcellini","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejim.2018.05.034_bb0060","series-title":"Immune hemolytic anemias","author":"Petz","year":"2004"},{"key":"10.1016\/j.ejim.2018.05.034_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ajh.23356","article-title":"Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases","volume":"88","author":"Kamesaki","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1537-2995.2008.01957.x","article-title":"Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies","volume":"49","author":"Arndt","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.ejim.2018.05.034_bb0075","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V69.3.820.820","article-title":"Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases","volume":"69","author":"Liesveld","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0080","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1001\/jama.1980.03310150024022","article-title":"Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency","volume":"244","author":"Conley","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2018.05.034_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/asheducation-2015.1.299","article-title":"The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)","volume":"2015","author":"Malcovati","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ejim.2018.05.034_bb0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/10245332.2016.1138621","article-title":"Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia","volume":"21","author":"Rattarittamrong","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.ejim.2018.05.034_bb0095","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00277-016-2750-7","article-title":"Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer","volume":"95","author":"Ureshino","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0100","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jgs.14167","article-title":"Autoimmune hemolytic anemia in individuals aged 75 and older: a study of 10 individuals","volume":"64","author":"Zulfiqar","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2018.05.034_bb0105","first-page":"199","article-title":"Agewise distribution of idiopathic cold agglutinin disease","volume":"26","author":"Hadnagy","year":"1993","journal-title":"Gerontol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0110","first-page":"460","article-title":"Primary chronic cold agglutinin disease: a population based clinical study of 86 patients","volume":"91","author":"Berentsen","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2018.05.034_bb0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2013-02-474437","article-title":"Cold agglutinin disease","volume":"122","author":"Swiecicki","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"Randen","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2018.05.034_bb0125","doi-asserted-by":"crossref","first-page":"635670","DOI":"10.1155\/2015\/635670","article-title":"Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia","volume":"2015","author":"Barcellini","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejim.2018.05.034_bb0130","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1002\/ajh.23800","article-title":"Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores","volume":"89","author":"Russo","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0135","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1182\/blood-2014-06-583021","article-title":"Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients","volume":"124","author":"Barcellini","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0140","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ajh.24047","article-title":"Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias","volume":"90","author":"Fattizzo","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0145","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood-2003-10-3597","article-title":"Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients","volume":"103","author":"Berentsen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0150","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood-2011-06-363556","article-title":"Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biological studies","volume":"119","author":"Barcellini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.12541","article-title":"A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia","volume":"163","author":"Birgens","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0160","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1515\/med-2016-0068","article-title":"Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia","volume":"11","author":"Giudice","year":"2016","journal-title":"Open Med (Wars)"},{"key":"10.1016\/j.ejim.2018.05.034_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejim.2010.12.016","article-title":"Rituximab therapy for autoimmune haematological diseases","volume":"22","author":"Barcellini","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0175","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood-2011-06-363556","article-title":"Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies","volume":"119","author":"Barcellini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00277-016-2605-2","article-title":"Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA","volume":"95","author":"Laribi","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bjh.15109","article-title":"How I manage patients with cold agglutinin disease","volume":"181","author":"Berentsen","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2012.01.002","article-title":"Tj\u00f8nnfjord GE diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia","volume":"26","author":"Berentsen","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.ejim.2018.05.034_bb0195","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/17474086.2015.1073105","article-title":"Current treatment strategies in autoimmune hemolytic disorders","volume":"8","author":"Barcellini","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0200","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/ajh.24618","article-title":"Clinical evolution of autoimmune cytopenias to idiopathic cytopenias\/dysplasias of uncertain significance (ICUS\/IDUS) and bone marrow failure syndromes","volume":"92","author":"Barcellini","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0210","unstructured":"Fattizzo B, Zaninoni A, Giannotta J, et al. Clinical follow-up of 378 patients with autoimmune hemolytic anemia: prognostic impact of hemoglobin levels, autoantibody class, and reticulocytopenia at onset on the relapse risk and outcome. 22nd European hematology association meeting. Madrid 2017. Poster abstract 616."},{"key":"10.1016\/j.ejim.2018.05.034_bb0215","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM196811072791902","article-title":"Chronic idiopathic neutropenia. A newly recognized entity?","volume":"279","author":"Kyle","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejim.2015.05.019","article-title":"Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study","volume":"26","author":"Fattizzo","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0609.2001.00473.x","article-title":"Non-immune chronic idiopathic neutropenia of adult: an overview","volume":"67","author":"Papadaki","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1096-8652(200012)65:4<271::AID-AJH1>3.0.CO;2-R","article-title":"Patients with chronic idiopathic neutropenia of adults have increased serum concentrations of inflammatory cytokines and chemokines","volume":"65","author":"Papadaki","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0235","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2141.2005.05380.x","article-title":"Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia","volume":"128","author":"Papadaki","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0240","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2006.06242.x","article-title":"Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow","volume":"134","author":"Psyllaki","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0245","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3324\/haematol.2011.053983","article-title":"Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia","volume":"97","author":"Pavlaki","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2018.05.034_bb0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/17474086.1.2.217","article-title":"Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia","volume":"1","author":"Papadaki","year":"2008","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0260","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s002770050518","article-title":"Prevalence of chronic idiopathic neutropenia of adults among an apparently healthy population living on the island of Crete","volume":"78","author":"Papadaki","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0265","first-page":"91","article-title":"Detection of anti-neutrophil antibodies in autoimmune neutropenia of infancy: a multicenter study","volume":"12","author":"Sella","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ejim.2018.05.034_bb0270","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2141.1978.tb01106.x","article-title":"Autoimmune granulocytopenia: the detection of granulocyte autoantibodies with the immunofluorescence test","volume":"39","author":"Verheugt","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","article-title":"Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases","volume":"91","author":"Bux","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0280","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/8756-3282(87)90015-9","article-title":"Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study","volume":"8","author":"Burkhardt","year":"1987","journal-title":"Bone"},{"key":"10.1016\/j.ejim.2018.05.034_bb0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.1989.tb00230.x","article-title":"Long term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin","volume":"73","author":"De Planque","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0295","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0300","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/leu.2013.30","article-title":"Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia","volume":"27","author":"Lane","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejim.2018.05.034_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0310","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","article-title":"Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome","volume":"124","author":"Kulasekararaj","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0315","series-title":"The drug etiology of agranulocytosis and aplastic anemia","author":"Kaufman","year":"1991"},{"key":"10.1016\/j.ejim.2018.05.034_bb0320","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood.V77.10.2166.2166","article-title":"Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group","volume":"77","author":"Issaragrisil","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0325","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","article-title":"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia","volume":"99","author":"Bacigalupo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0330","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V45.3.355.355","article-title":"Selection of patients for bone marrow transplantation in severe aplastic anemia","volume":"45","author":"Camitta","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0037-1963(00)90031-3","article-title":"Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy \u2013 The European group for blood and marrow transplantation experience","volume":"37","author":"Bacigalupo","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0340","first-page":"503","article-title":"Telomere length, expression of MRE11 and Ku80 in patients with aplastic anemia and their correlation with pathogenesis","volume":"25","author":"Wang","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.ejim.2018.05.034_bb0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2018.05.034_bb0350","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"British Society for Standards in Haematology. Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0360","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0365","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7326\/0003-4819-130-3-199902020-00004","article-title":"For the European group for blood and marrow transplantation severe aplastic anaemia working party: effectiveness of immunosuppressive therapy in older patients with aplastic anemia","volume":"130","author":"Tichelli","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0370","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"Scheinberg","year":"2009","journal-title":"Br J Haematol Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0375","doi-asserted-by":"crossref","unstructured":"Bacigalupo A, Oneto R, Schrezenmeier H, et al. First line treatment of aplastic anemia with thymoglobuline in Europa and Asia: outcome of 976 patients treated 2001\u20132012. 58th American society of hematology meeting. Abstract 2422.","DOI":"10.1182\/blood.V128.22.2422.2422"},{"key":"10.1016\/j.ejim.2018.05.034_bb0380","article-title":"Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia","volume":"7","author":"Tjon","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0385","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1182\/blood-2010-08-304071","article-title":"A randomized controlled study in newly-diagnosed severe aplastic anemia patients receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA working party of the EBMT","volume":"117","author":"Tichelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0390","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.1993.tb04645.x","article-title":"Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party","volume":"83","author":"Bacigalupo","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2018.05.034_bb0395","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0400","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.05.034_bb0405","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood.V128.22.3900.3900","article-title":"Androgens may boost responses to anti-thymocyte globulin in acquired aplastic anemia","volume":"128","author":"Giammarco","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0410","doi-asserted-by":"crossref","first-page":"LBA2","DOI":"10.1182\/blood.V126.23.LBA-2.LBA-2","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia accelerates count recovery and increases response rates","volume":"126","author":"Townsley","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.05.034_bb0415","doi-asserted-by":"crossref","unstructured":"Lengline E, Peffault R. Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: report on behalf of the French reference center for aplastic anemia. 58th American society of hematology meeting. Abstract 2684.","DOI":"10.1182\/blood.V128.22.2684.2684"},{"key":"10.1016\/j.ejim.2018.05.034_bb0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/asheducation-2000.1.18","article-title":"New insights into the pathophysiology of acquired cytopenias","author":"Young","year":"2000","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ejim.2018.05.034_bb0425","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM199310143291603","article-title":"Malignant tumors occurring after treatment of aplastic anemia. European bone marrow transplantation-severe aplastic Anaemia working party","volume":"329","author":"Soci\u00e9","year":"1993","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518302309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518302309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T21:53:25Z","timestamp":1694469205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518302309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":85,"alternative-id":["S0953620518302309"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.05.034","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}